KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Assets Average: 2012-2025

Historic Assets Average for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Sep 2025 value amounting to $1.4 billion.

  • Supernus Pharmaceuticals' Assets Average rose 5.40% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 5.40%. This contributed to the annual value of $1.3 billion for FY2024, which is 11.22% down from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Assets Average is $1.4 billion, which was up 2.65% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Assets Average ranged from a high of $1.7 billion in Q1 2023 and a low of $1.3 billion during Q4 2023.
  • In the last 3 years, Supernus Pharmaceuticals' Assets Average had a median value of $1.4 billion in 2024 and averaged $1.4 billion.
  • In the last 5 years, Supernus Pharmaceuticals' Assets Average climbed by 28.14% in 2021 and then decreased by 26.12% in 2024.
  • Supernus Pharmaceuticals' Assets Average (Quarterly) stood at $1.6 billion in 2021, then rose by 4.67% to $1.7 billion in 2022, then decreased by 24.53% to $1.3 billion in 2023, then increased by 5.77% to $1.4 billion in 2024, then climbed by 5.40% to $1.4 billion in 2025.
  • Its Assets Average stands at $1.4 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.4 billion for Q1 2025.